Nasr S, Nsiri I, Fredj MB. Effectiveness of smoking cessation interventions for smokers with Crohn's disease: a systematic review.
Future Sci OA 2023;
9:FSO870. [PMID:
37485443 PMCID:
PMC10357394 DOI:
10.2144/fsoa-2022-0049]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2022] [Accepted: 05/10/2023] [Indexed: 07/25/2023] Open
Abstract
Aims
Smoking cessation (SC) in Crohn's disease (CD) is widely accepted to be the most important modifiable factor to improve outcomes in these patients. We aimed in this review to provide a summary of the evidence base regarding the effectiveness of SC interventions in patients with CD.
Materials & methods
The following databases were systematically searched from inception to February 2022: PubMed, Google Scholar and Cochrane Library.
Results
Overall, five articles met the research criteria. Studies sample size ranged from 17 to 474 patients. At the outcome level, the abstinence rates ranged from 14.8 to 42% and was ≤25% in four studies. The three studies with control groups did not report statistically higher SC rates in the intervention groups. No predictors of interventions success were identified in this review.
Conclusion
Implementation and evaluation of tailored SC interventions for CD patients must be promptly addressed in further studies.
Collapse